Tiny implant could replace hormone shots for prostate cancer

This early-stage study is testing whether a small, drug-releasing implant placed directly into the prostate can safely replace standard hormone-blocking injections for men with localized prostate cancer. The implant delivers a drug called bicalutamide locally, and participants also receive standard radiation therapy. Researchers aim to see if this targeted approach is feasible and well-tolerated while avoiding the body-wide side effects of traditional hormone therapy.